Biomerica Inc. (BMRA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Biomerica Inc., updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$1.75
+1.73% today
Market cap
$8M
Overall quality
26/100
Kronos AI 30-day
+4.1%
7 of 8 simulated paths end higher
Biomerica Inc. (BMRA) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $8M. It trades at $1.75, up 1.73% today. Its overall quality score is 26 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +4.1% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.78 (+4.1%) |
| Likely range | +0.2% … +6.7% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 11 |
| Solvency | 45 |
| Growth | 23 |
| Overall | 26 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.